
### [MONDO:0007670](http://purl.obolibrary.org/obo/MONDO_0007670)
**Label:** hypotrichosis-lymphedema-telangiectasia syndrome (grouping)

**Subclasses:** [MONDO:0011914](http://purl.obolibrary.org/obo/MONDO_0011914) (hypotrichosis-lymphedema-telangiectasia syndrome), [MONDO:0019073](http://purl.obolibrary.org/obo/MONDO_0019073) (hypotrichosis-lymphedema-telangiectasia-renal defect syndrome), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0072091](http://purl.obolibrary.org/obo/GO_0072091) (regulation of stem cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0022405](http://purl.obolibrary.org/obo/GO_0022405) (hair cycle process), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0042789](http://purl.obolibrary.org/obo/GO_0042789) (mRNA transcription by RNA polymerase II), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0048866](http://purl.obolibrary.org/obo/GO_0048866) (stem cell fate specification), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0060836](http://purl.obolibrary.org/obo/GO_0060836) (lymphatic endothelial cell differentiation), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0061028](http://purl.obolibrary.org/obo/GO_0061028) (establishment of endothelial barrier), [GO:0060214](http://purl.obolibrary.org/obo/GO_0060214) (endocardium formation), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), 

**Class expressions from DL-Learner:**

- [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation) 55.00%
- [GO:0060836](http://purl.obolibrary.org/obo/GO_0060836) (lymphatic endothelial cell differentiation) 55.00%
- [GO:0060214](http://purl.obolibrary.org/obo/GO_0060214) (endocardium formation) 55.00%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 55.00%
- [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development) 55.00%
- [GO:0009792](http://purl.obolibrary.org/obo/GO_0009792) (embryo development ending in birth or egg hatching) 55.00%
- [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development) 55.00%
- [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development) 55.00%
- [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis) 55.00%
- [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development) 55.00%
- [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development) 55.00%
- [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development) 55.00%
- Thing 52.02%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 47.45%
- [GO:0045446](http://purl.obolibrary.org/obo/GO_0045446) (endothelial cell differentiation) 45.36%


